Greyson International Inc. (OTC Pink Sheets: GYSN), developer of an innovative patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that it recruited Tia Castle for the position of Brand Manager and Beauty Spokes Person for Greyson Skincare with Trilexon® technology.

Tia Castle, Brand Manager and Beauty Spokes Person for Greyson International, Inc. (Photo: Business Wire)

"Tia brings more than 15 years’ experience in both pharmaceutical sales and marketing with drug giant Johnson & Johnson (J&J). She is also an established on-air TV and film personality," said Harvey Tauman, CEO of Greyson Inc. Ms. Castle's immediate role will be to manage the launch of Greyson Skincare on shopping networks, targeted for later this year, and appear as the on-air spokesperson. “I am excited to come on board full time, as I believe in Greyson’s ability to become a worldwide leader in skincare and pharmaceuticals. The potential to help companies stave off and recover from the 'patent cliff' is an enormous opportunity that needs immediate implementation," said Tia Castle.

The “patent cliff” is a big pharma company problem whereby brand name drugs that have delivered steady sales and profits are losing their patent protection. Greyson’s next news release will be detailing how their Trilexon® delivery system will give hope to the industry regarding the potential $90 billion loss.

Greyson International’s revolutionary patented Trilexon® delivery system allows the finest ingredients to be released topically over an extended period of time, while maintaining the skin’s natural intracellular barrier to promote natural moisture and lipid levels, providing a comfortable and durable experience that’s unlike anything else in the market.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. For more information, visit our website; http://greysonintl.com and join the Greyson International's Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Greyson International Inc.Harvey Tauman, 954-482-0497Chief Executive OfficerHarvey@greysonintl.com

Greyson (CE) (USOTC:GYSN)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Greyson (CE).
Greyson (CE) (USOTC:GYSN)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Greyson (CE).